Jeil Pharmaceutical Co Ltd (271980) — Strategic Asset Allocation Index
Jeil Pharmaceutical Co Ltd (271980) has a Strategic Asset Allocation Index of 82.1% as of June 2023. Strategic assets (PP&E of ₩137.93 Billion plus long-term investments of ₩-) total ₩137.93 Billion, measured against net assets of ₩167.96 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Jeil Pharmaceutical Co Ltd Strategic Asset Allocation Index (2017–2021)
This chart shows how Jeil Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 5 annual periods from 2017 to 2021. As of June 2023, the index stands at 82.1%, representing strategic assets of ₩137.93 Billion against net assets of ₩167.96 Billion KRW. Explore cash flow conversion of Jeil Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Jeil Pharmaceutical Co Ltd (2017–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Jeil Pharmaceutical Co Ltd from 2017 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Jeil Pharmaceutical Co Ltd (271980) market capitalisation.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 75.1% | ₩125.71 Billion | ₩125.71 Billion | ₩- | ₩167.35 Billion | ▲ +8.1 pp |
| 2020 | 67.0% | ₩115.55 Billion | ₩115.55 Billion | ₩- | ₩172.48 Billion | ▼ -3.8 pp |
| 2019 | 70.8% | ₩120.44 Billion | ₩120.44 Billion | ₩- | ₩170.04 Billion | ▲ +5.2 pp |
| 2018 | 65.7% | ₩121.46 Billion | ₩120.48 Billion | ₩977.95 Million | ₩184.93 Billion | ▲ +6.3 pp |
| 2017 | 59.4% | ₩105.68 Billion | ₩102.66 Billion | ₩3.03 Billion | ₩177.99 Billion | — |